Drug
Metformin Gliclazide Fixed Combination
Metformin Gliclazide Fixed Combination: highest development phase Phase 1, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Metformin/Gliclazide Fixed Combination NCT03467945 | Phase 1 | Healthy |
Latest
No recent events.
Follow Metformin Gliclazide Fixed Combination on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.